MYB and cancer: Since MYB is overexpressed in many cancers including leukemia, breast, and colorectal cancers (27, 53, 54, 55, 56, 57), it may under these conditions be less SUMO-repressed according to the autoactivation hypothesis due to the deregulation of SENP1 expression.